 CVS Health Corp. stock CVS, -0.08 soared 5 in premarket trade Wednesday, after the company announced a 5 billion settlement of opioid claims and third-quarter earnings blew past estimates. The company swung to a loss of 3.409 billion, or 2.60 a share, for the third quarter, after income of 1.587 billion, or 1.20 a share, in the year-earlier period. 